OOIR: Observatory of International Research

Papers

(The TQCC of Cytometry Part B-Clinical Cytometry is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Issue highlights—January 2025	44
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease	42
	30
An uncommon case of acute megakaryoblastic leukemia with DDX3X :: MLLT10	28
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells	28
	18
	18
Standardization of flow cytometric detection of antigen expression	17
Issue highlights—September 2023	17
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients	16
Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel	16
	15
Issue Information	15
Frequency and stability of populations of CD4⁺ and CD4⁺CD25⁺Foxp3⁺CD127^lo Treg in healthy adults defi	14
Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis	14
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma	13
A 20‐color 21‐antigen flow cytometric assay for disease monitoring of T‐cell lymphoblastic leukemia	12
Issue Information	12
Defining atypical chronic lymphocytic leukemia for reproducible diagnosis: implications of the work by Wang et al.	12
Issue Information	11
Issue Information	10
Basophilic blast crisis of chronic myelogenous leukemia presenting de novo: Diagnostic contribution of flow cytometry	10
CD133 in T ‐lymphoblastic leukemia is preferentially expressed in early T	9
Converting an HLA‐B27 flow assay from the BD FACSCanto to the BD FACSLyric	9
ROR1 expression in mature B lymphoid neoplasms by flow cytometry	9

Whole blood no‐lyse no‐wash micromethod for the quantitative measurement of monocyte HLA‐DR	9
A novel flow cytometry approach to quantify malaria‐derived particles	9
Issue Information	9
Alignment, segmentation and neighborhood analysis in cyclic immunohistochemistry data using CASSATT	8
Integrating immune profiling and clinical features for early prediction of chronicity in pediatric immune thrombocytopenia	8
Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays	8
Issue Information	8
Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry	8
SingletSeeker: An unsupervised clustering approach for automated singlet discrimination in cytometry	7
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia	7
Appropriate interpretation of TRBC1‐dim positive subsets in T‐cell immunophenotyping by flow cytometry	7
Implementation of a one‐tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine	7
Enhancing HLA‐B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis	7
	7
International Clinical Cytometry Society 2023 workload survey of clinical flow cytometry laboratories	6
Issue Information	6
Anti‐ CD38 VHH antibody ( JK36 ) reliably detects CD38	6
	6
Correction to “Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet	6
Flow cytometry‐based monitoring of chimeric antigen receptor ( CAR ) T cells: Reagent selection, assay design, and clinical utility	5
Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel—recommendations and safeguards for clinical laboratories	5
Characterization of CD123 expression by mast cells in systemic mastocytosis with multicolor flow cytometry	5
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds	5
Remembering Dr. Bruce H. Davis: A passionate leader in clinical flow cytometry	5
Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care	5
Exercise affects systemic basophil responses in humans: Applying an automated and modified basophil activation test ( mBAT ) in a field study	5
Monocyte maturation pattern by flow cytometry expression of CD64, CD300e, and CD14 correlates to presence of myeloid neoplasm and helps identify blast equivalents in t	5
Editorial on IVD cellular assay validation	5
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring	5
Possible alternative strategies to implement basophil activation testing in multicentric studies	5
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup	5
Prospective validation of podoplanin expression as a diagnostic biomarker of acute promyelocytic leukemia	5
Optimizing the diagnosis of chronic granulomatous disease using dihydrorhodamine‐123 assay: Lessons from a large monocentric cohort	5
Automated analysis of flow cytometry data with minimal training files: Research evaluation of an elastic image registration algorithm for TBNK, stem cell enumeration, and lymphoid screening	5
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience	5
Issue Highlights—July 2022	5
Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases	5
CD38, CD39, and BCL2 differentiate disseminated forms of high‐grade B‐cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B‐cell lymphoma	4
Glucose‐6‐phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation	4
Issue highlights—November 2024	4
Issue Highlights—November 2025	4
28‐color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease	4
Issue Information	4
Signal without noise: Practical antibody titration for platelet flow cytometry	4
Stabilization of bronchoalveolar lavage cells for postponed flow cytometric analysis	4
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry	4
Analysis of immunophenotypic changes in acute megakaryoblastic leukemia after treatment	4
	4
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis	4
Increased IFN‐γ⁺ and TNF‐α⁺ mucosal‐associated invariant T cells in patients with aplastic anemia	4

Issue Highlights—July 2025	4
	4
Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis	4